Eosinophilia: Difference between revisions

Line 6: Line 6:


==Differential Diagnosis==
==Differential Diagnosis==
*[[Allergic reaction]] or other hypsersensitivity/atopic state
*[[Allergic reaction]] or other hypersensitivity/atopic state
**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
*[[DRESS syndrome]], drug-induced
*[[DRESS syndrome]], drug-induced
Line 14: Line 14:
*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)
*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)
*[[Adrenal insufficiency]]
*[[Adrenal insufficiency]]
*Connective tissue disease (e.g. [[Churg-Strauss syndrome]])
*[[Connective tissue disease]] (e.g. [[Churg-Strauss syndrome]])
*Interstitial nephritis
*Interstitial nephritis
*[[Arsenic]], [[gold toxicity]]
*[[Arsenic]], [[gold toxicity]]

Revision as of 00:25, 1 October 2019

Background

  • Defined usually as peripheral eosinophil count >0.5 x 109/L
  • Eosinophils normally comprise <7% of total WBC count

Clinical Features

Differential Diagnosis

Evaluation

Management

Disposition

See Also

External Links

References